These reports originally appeared in the February issue of Neurology Alert. At that time it was peer reviewed by M. Flint Beal, MD, Anne Parrish Titzel Professor, Department of Neurology and Neuroscience, Weill Cornell Medical Center, New York, NY. Dr. Beal reports no financial relationship to this field of study.
Spironolactone may save the day with resistant hypertension.
Dietary fiber intake appears to lower all-cause mortality, including death from cardiovascular, infectious, and respiratory diseases.
Elderly patients with depression respond favorably to bright light treatment.
The fda has approved a new topical treatment for head lice infestation.
Lower plasma levels of b-amyloid 42/40 in elderly persons followed over 9 years were associated with greater cognitive decline, mainly in those with low measures of past education and literacy.
The patient asks, "Is it safe to take?" You pause, thinking, the FDA classifies it as a Category C, and everybody seems to use it, but how can anybody be sure? So, you finally respond, "It has been used a lot in pregnant patients and no harmful effects have been observed." But, you say to yourself, am I really confident? What would I do for myself or my spouse if in the same situation?